12-methoxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-19-[(Z)-3-methyl-4-oxo-4-piperidin-1-ylbut-2-enyl]-8-(4-methylpent-3-enyl)-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4,6(11),9,12,15-pentaene-14,18-dione

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 12-methoxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-19-[(Z)-3-methyl-4-oxo-4-piperidin-1-ylbut-2-enyl]-8-(4-methylpent-3-enyl)-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4,6(11),9,12,15-pentaene-14,18-dione
• 化学式: C₄₄H₅₅NO₇
• 分子量: 709.9
• InChiKey: GOUWDBJEHQYVJZ-QRQIAZFYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.9
• 重原子数：
  52
• 可旋转键数：
  9
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  91.4
• 氢给体数：
  0
• 氢受体数：
  7

文献信息

• GAMBOGIC ACID GLYCOSIDE DERIVATIVES AND ANALOGS, THEIR PREPARATION METHODS AND APPLICATIONS
  申请人：Xu Lifeng

  公开号：US20110038952A1

  公开（公告）日：2011-02-17

  This invention relates with the gambogic acid glycoside derivatives and analogs of formula I: or stereoisomers, tautoers, prodrugs, pharmaceutically acceptable salts, complex salts or solvates thereof, wherein: X 1 , X 2 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 or/and R 12 is, independently at each occurrence, optionally substituted glycosyl, optionally substituted multi-hydroxyl, optional substituent oxy, optional substituent containing carbon, oxygen, sulfur, nitrogen or phosphorus element. Compounds of the present invention are useful as therapeutically effective agents of anti-cancer, anti-virus and anti-bacterial. This invention also relates with their preparative methods and applications.